MicroRNA: novel modulators of the cholinergic anti-inflammatory pathway

Medha Priyadarshini1, N A Arivarasu, Aaliya Shah

  • 1Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, U.P., India. medha.priyadarshini@gmail.com

Insights

MicroRNAs (miRNAs) are crucial gene regulators in the nervous system, impacting neural function and disorders. Emerging research highlights their role in fine-tuning immune responses and the neuro-immune dialogue.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression, particularly abundant and precisely controlled in the nervous system.
  • Neural miRNAs are implicated in critical processes like neural differentiation, synaptogenesis, memory, and cognition.
  • Dysregulation of miRNA expression is linked to neurodegenerative, neuroinflammatory, and stress-related disorders.

Purpose of the Study:

  • To explore the multifaceted roles of miRNAs in neural function and their connection to immune system regulation.
  • To investigate the involvement of miRNAs in neuro-immune dialogue and their impact on neuroinflammation and related disorders.

Main Methods:

  • Review of current literature on miRNA function in the nervous system.
  • Analysis of studies investigating miRNA involvement in immune cell development and function.
  • Examination of research on miRNA-mediated signaling in neuro-immune interactions.

Main Results:

  • Neural miRNAs play vital roles in regulating neural development, function, and cognitive processes.
  • miRNAs are essential for modulating immune responses, including myeloid and lymphoid cell maturation and differentiation.
  • miRNAs directly influence immune signaling pathways, such as Toll-like receptor pathways, affecting cytokine production.

Conclusions:

  • MicroRNAs are critical regulators in both the nervous and immune systems.
  • Emerging evidence points to miRNAs as key mediators of the neuro-immune dialogue.
  • Understanding miRNA function is crucial for developing therapeutic strategies for neuro-immune disorders.

Related Concept Videos

Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...